Skip to main content
. 2019 Aug 23;98(34):e16961. doi: 10.1097/MD.0000000000016961

Figure 3.

Figure 3

Funnel plots showing no significant publication bias in the different subgroups. (A) Arrhythmic events: flecainide monotherapy versus standard therapy; (B) arrhythmic events: combination therapy versus β-blocker monotherapy; (C) symptomatic events: combination therapy versus β-blocker monotherapy; (D) side effects: flecainide versus β-blocker.